RXRX

Recursion Pharmaceuticals
RXRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.00B
EV
$1.59B
Shares Outstanding
406.92M
Beta
0.83

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$7.57
P/E 2025E
-
P/Revenue 2025E
26.96x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Recursion Pharmaceuticals, Inc.

gainify
RXRX

Recursion Pharmaceuticals, Inc.

RXRX

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The compa...

Sector

Healthcare

Industry

Biotechnology

CEO

Gibson, Christopher

Employees

800

IPO Date

2021-04-16

Headquarters

41 South Rio Grande Street, Salt Lake City, Utah, 84101, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.